DIalysis Symptom COntrol-Pruritus Outcome Trial
NCT05180968
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Pruritus
Interventions
DRUG:
Nabilone 0.5 MG Oral Capsule
DRUG:
Placebo Nabilone
Sponsor
University of Manitoba
Collaborators
[object Object]